Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation

Background Everolimus permits reduced calcineurin inhibitor (CNI) exposure, but the efficacy and safety outcomes of this treatment after kidney transplant require confirmation. Methods In a multicenter noninferiority trial, we randomized 2037 de novo kidney transplant recipients to receive, in combi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Am Soc Nephrol
Main Authors: Pascual, Julio, Berger, Stefan P., Witzke, Oliver, Tedesco, Helio, Mulgaonkar, Shamkant, Qazi, Yasir, Chadban, Steven, Oppenheimer, Federico, Sommerer, Claudia, Oberbauer, Rainer, Watarai, Yoshihiko, Legendre, Christophe, Citterio, Franco, Henry, Mitchell, Srinivas, Titte R., Luo, Wen-Lin, Marti, AnaMaria, Bernhardt, Peter, Vincenti, Flavio
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Nephrology 2018
Fag:
Clinical Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6050928/
https://ncbi.nlm.nih.gov/pubmed/29752413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018010009
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker